Literature DB >> 28503714

Depression severity and concentration difficulties are independently associated with HRQOL in patients with unipolar depressive disorders.

A Fattori1, L Neri2, A Bellomo3, M Vaggi4, C Mencacci5.   

Abstract

PURPOSE: Cognitive impairment is a core feature of major depressive disorder (MDD), and dysfunctions in this area strongly contribute to MDD-associated disability. Whether cognitive impairment has an independent clinical course and a unique impact on HRQOL is still debated. We sought to characterize the relationship between depression severity and HRQOL, evaluating the burden of concentration difficulties on HRQOL.
METHODS: Six hundred ninety-two patients with unipolar depressive disorders recruited in 19 Italian centers answered a self-administered survey (SF-12 questionnaire, socio-demographic information). A psychiatrist completed a standardized data collection form encompassing a depression severity scale (MADRS) and clinical information.
RESULTS: There was a strong graded association between the severity of depressive symptoms and both the physical (ω 2 = 0.13; p < 0.01) and mental (ω 2 = 0.34; p < 0.01) SF-12 domains. Additionally, we observed a strong association between concentration difficulties and all HRQOL outcomes independent of other symptoms of depression and robust to adjustment for possible confounders.
CONCLUSIONS: Our data corroborate previous findings suggesting that cognitive impairment is a feature of unipolar depressive disorders partially independent of the severity of other symptoms, and may represent a specific target of therapy with a strong impact on patients' functioning and quality of life.

Entities:  

Keywords:  Cognitive impairment; Depression severity; HRQoL; MADRS; SF-12; Unipolar depressive disorder

Mesh:

Year:  2017        PMID: 28503714     DOI: 10.1007/s11136-017-1595-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  58 in total

1.  Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life?

Authors:  A G E M de Boer; J J B van Lanschot; P F M Stalmeier; J W van Sandick; J B F Hulscher; J C J M de Haes; M A G Sprangers
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

2.  Comparison of quality of life measures in a depressed population.

Authors:  Stephen R Wisniewski; A John Rush; Charlene Bryan; Richard Shelton; Madhukar H Trivedi; Sheila Marcus; Mustafa M Husain; Steven D Hollon; Maurizio Fava
Journal:  J Nerv Ment Dis       Date:  2007-03       Impact factor: 2.254

3.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

4.  Cognitive impairment in the euthymic phase of chronic unipolar depression.

Authors:  S Paradiso; G J Lamberty; M J Garvey; R G Robinson
Journal:  J Nerv Ment Dis       Date:  1997-12       Impact factor: 2.254

5.  Cognitive impairment in the euthymic phase of affective disorder.

Authors:  L V Kessing
Journal:  Psychol Med       Date:  1998-09       Impact factor: 7.723

6.  The dissociation of explicit and implicit memory in depressed patients.

Authors:  N Bazin; P Perruchet; M De Bonis; A Féline
Journal:  Psychol Med       Date:  1994-02       Impact factor: 7.723

7.  The frequency of cognitive impairment in patients with anxiety, depression, and bipolar disorder: an unaccounted source of variance in clinical trials.

Authors:  C Thomas Gualtieri; Dexter W Morgan
Journal:  J Clin Psychiatry       Date:  2008-07       Impact factor: 4.384

Review 8.  Treatment of cognitive dysfunction in major depressive disorder--a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine.

Authors:  Alan L Pehrson; Steven C Leiser; Maria Gulinello; Elena Dale; Yan Li; Jessica A Waller; Connie Sanchez
Journal:  Eur J Pharmacol       Date:  2014-08-05       Impact factor: 4.432

Review 9.  Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints.

Authors:  Michael Camilleri; Allen W Mangel; Sheri E Fehnel; Douglas A Drossman; Emeran A Mayer; Nicholas J Talley
Journal:  Clin Gastroenterol Hepatol       Date:  2007-04-11       Impact factor: 11.382

10.  Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed.

Authors:  B C Beats; B J Sahakian; R Levy
Journal:  Psychol Med       Date:  1996-05       Impact factor: 7.723

View more
  3 in total

1.  The severity of psychiatric disorders.

Authors:  Mark Zimmerman; Theresa A Morgan; Kasey Stanton
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

2.  An End-to-End Depression Recognition Method Based on EEGNet.

Authors:  Bo Liu; Hongli Chang; Kang Peng; Xuenan Wang
Journal:  Front Psychiatry       Date:  2022-03-11       Impact factor: 4.157

3.  Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study.

Authors:  Delphine Saragoussi; Michael Cronquist Christensen; Lene Hammer-Helmich; Benoît Rive; Maëlys Touya; Josep Maria Haro
Journal:  Neuropsychiatr Dis Treat       Date:  2018-05-22       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.